Definition and epidemiology
Raynaud syndrome refers to episodic digital vasospasm triggered by cold exposure or emotional stress, leading to transient ischemia of the fingers, toes, and occasionally ears, nose, or nipples.
- Primary Raynaud (Raynaud disease): idiopathic, no associated systemic disease, benign course
- Secondary Raynaud (Raynaud phenomenon): associated with an underlying disorder, most commonly systemic sclerosis (scleroderma), but also systemic lupus erythematosus, mixed connective tissue disease, Sjögren syndrome, or dermatomyositis
Primary Raynaud accounts for the large majority of cases (roughly 80-90%) and typically begins in the teens to twenties. It is several times more common in women than men. Secondary Raynaud tends to present later in life, is less common, but carries greater clinical significance because it can be the earliest manifestation of an underlying connective tissue disease, sometimes preceding other symptoms by years.
- Triphasic color change: white (ischemia) -> blue (cyanosis) -> red (reperfusion)
- Primary Raynaud: young women, symmetric, normal nailfold capillaries, normal ANA
- Secondary Raynaud strongly associated with systemic sclerosis; may precede skin changes by years
- Abnormal nailfold capillaroscopy points to secondary disease
- First-line drug therapy: dihydropyridine calcium channel blockers (e.g., nifedipine)
- Digital ulcers/gangrene suggest secondary Raynaud, not primary
- Beta-blockers and ergot alkaloids can trigger or worsen Raynaud
- Severe digital ischemia in scleroderma may require IV prostacyclin analogs (iloprost)
Etiology and risk factors
Primary Raynaud
- Family history is common; likely polygenic predisposition
- Exaggerated sympathetic vasoconstrictor response to cold or stress without identifiable disease
- Risk factors: female sex, young age, smoking, family history, cold climate
Secondary Raynaud
- Connective tissue diseases: systemic sclerosis (very high association), SLE, Sjögren syndrome, dermatomyositis/polymyositis, mixed connective tissue disease
- Occupational/vibration injury: hand-arm vibration syndrome (e.g., jackhammer operators)
- Drugs: beta-blockers, ergot alkaloids, bleomycin, cisplatin, clonidine, amphetamines, cocaine
- Hematologic: cryoglobulinemia, polycythemia vera, cold agglutinin disease
- Vascular: thoracic outlet syndrome, atherosclerosis
- Endocrine: hypothyroidism
- Smoking worsens vasospasm in both forms
Pathophysiology
Normal cold exposure causes mild cutaneous vasoconstriction to conserve heat; in Raynaud syndrome, this response is exaggerated and prolonged due to abnormal regulation of vascular tone in digital arteries and arterioles.
- Increased alpha-2 adrenergic receptor sensitivity on vascular smooth muscle in digital vessels promotes excessive vasoconstriction with cold or sympathetic stimulation
- Endothelial dysfunction reduces vasodilator mediators (nitric oxide) and increases vasoconstrictor mediators (endothelin-1)
- In secondary Raynaud, structural vascular changes (intimal proliferation, fibrosis) from the underlying connective tissue disease narrow the vessel lumen, making vasospasm more severe and more likely to cause tissue injury
- The color sequence reflects the physiology: pallor from vasospasm and reduced blood flow, cyanosis from stagnant deoxygenated blood, and rubor from reactive hyperemia upon rewarming
Clinical features
- Episodic, well-demarcated color change in fingers (most common), toes, or less often ears, nose, lips, or nipples
- Classic triphasic sequence: white -> blue -> red, though not all patients experience all three phases
- Episodes triggered by cold exposure, emotional stress, or sometimes vibration
- Numbness, tingling, or aching pain during the attack; throbbing or burning during rewarming/reperfusion
- Episodes typically last minutes, resolving with rewarming
- Symmetric and bilateral involvement is typical
Features suggesting secondary Raynaud
- Onset after age 30-40
- Asymmetric or single-digit involvement
- Digital ulcers, pitting scars, or gangrene
- Associated findings: skin thickening, telangiectasia, calcinosis, dysphagia, arthritis, photosensitive rash, sicca symptoms
- Abnormal nailfold capillaries
- Positive autoantibodies
Diagnosis
Diagnosis is largely clinical, based on history of cold- or stress-induced triphasic color changes. Further workup aims to distinguish primary from secondary disease.
History and examination
- Ask about age of onset, symmetry, triggers, digital ulceration, and associated systemic symptoms
- Examine for sclerodactyly, telangiectasia, calcinosis, digital pitting/ulcers
Key investigations
- Nailfold capillaroscopy: normal in primary Raynaud; abnormal (dilated capillary loops, dropout, avascular areas) suggests secondary disease, especially systemic sclerosis
- Antinuclear antibody (ANA): screening test; positive in most patients with connective tissue disease-associated Raynaud
- Specific autoantibodies if ANA positive or clinical suspicion: anti-centromere and anti-Scl-70 (systemic sclerosis), anti-dsDNA/anti-Sm (SLE), anti-U1-RNP (MCTD)
- CBC, ESR/CRP, TSH as indicated by clinical picture
- Pulse oximetry/digital plethysmography can document reduced perfusion during an episode but is not routinely needed
Diagnostic approach
| Feature | Primary Raynaud | Secondary Raynaud |
|---|---|---|
| Age of onset | Teens-20s | Usually >30 |
| Symmetry | Symmetric | Often asymmetric |
| Nailfold capillaroscopy | Normal | Abnormal |
| ANA | Negative | Often positive |
| Digital ulcers/gangrene | Absent | May be present |
| Course | Benign | May progress with underlying disease |
Differential diagnosis
- Acrocyanosis: persistent (not episodic) blue discoloration of hands/feet, painless, no pallor phase
- Chilblains (pernio): localized inflammatory lesions after cold exposure, can blister/ulcerate
- Thromboangiitis obliterans (Buerger disease): smoker, distal limb ischemia, often with ulceration, not purely episodic
- Peripheral arterial disease/atherosclerosis: fixed, not episodic; diminished pulses
- Erythromelalgia: episodic redness, warmth, and burning pain (opposite pattern, vasodilation not vasoconstriction)
- Hand-arm vibration syndrome: occupational vibration exposure history
- Cryoglobulinemia or cold agglutinin disease: hematologic workup abnormal
Management
General/lifestyle measures (first-line for all patients)
- Avoidance of cold exposure; use of gloves, hand/foot warmers, layered clothing
- Smoking cessation (nicotine worsens vasospasm)
- Avoidance of triggering drugs (beta-blockers, decongestants, stimulants) when possible
- Stress management techniques
- Minimize caffeine if it worsens symptoms (evidence limited)
Pharmacologic therapy
Reserved for frequent, severe, or ulcerating episodes not controlled by lifestyle measures.
- First-line: dihydropyridine calcium channel blockers (e.g., nifedipine, amlodipine) — reduce frequency and severity of attacks
- Second-line/add-on options: topical nitrates, phosphodiesterase-5 inhibitors (sildenafil), angiotensin receptor blockers (losartan), selective serotonin reuptake inhibitors (fluoxetine)
- Severe/refractory or digital ischemia with ulceration: intravenous prostacyclin analogs (iloprost), endothelin receptor antagonists (bosentan) for recurrent digital ulcers in systemic sclerosis
- Surgical digital sympathectomy considered in severe refractory cases with critical ischemia
Management of secondary Raynaud
- Treat the underlying connective tissue disease
- More aggressive vasodilator therapy given higher risk of digital ulceration and gangrene
- Close monitoring for digital ischemia requiring prompt escalation of therapy
Guideline consensus (ACR, EULAR) agrees on calcium channel blockers as first-line pharmacologic therapy; choice of second-line agents varies by regional guideline and severity, with PDE-5 inhibitors and prostacyclin analogs favored in European guidelines for refractory/ischemic disease.
Complications and prognosis
- Primary Raynaud: generally benign, excellent prognosis, no tissue damage; symptoms may improve or persist long-term without progression
- Secondary Raynaud: risk of digital ulceration, pitting scars, critical digital ischemia, and in severe cases gangrene requiring amputation
- Recurrent digital ulcers increase risk of infection
- Prognosis in secondary disease depends largely on control of the underlying connective tissue disease
- Any patient with new-onset Raynaud and atypical features should be monitored over time, as secondary disease (particularly systemic sclerosis) may not be apparent at initial presentation and can emerge later
Raynaud color sequence 'WBC' (White-Blue-Crimson/red) = ischemia, cyanosis, reperfusion hyperemia.
Practice questions
1. A 24-year-old woman reports that her fingers turn white, then blue, then red whenever she is exposed to cold weather, lasting a few minutes each time. She has no other symptoms, and physical examination including nailfold capillaroscopy is normal. Which of the following best describes her condition?
2. A 45-year-old woman with a 1-year history of Raynaud phenomenon presents with new digital pitting ulcers, skin tightening over her fingers, and difficulty swallowing. Nailfold capillaroscopy shows capillary dropout and dilated loops. Which autoantibody is most specifically associated with the diffuse cutaneous form of the disease most likely causing her symptoms?
3. A 52-year-old man with limited cutaneous systemic sclerosis has frequent, painful Raynaud attacks with early digital ulceration despite lifestyle modification and amlodipine. Which of the following is the most appropriate next step in management for severe digital ischemia?
Frequently asked questions
What causes Raynaud syndrome?
Raynaud syndrome is caused by exaggerated vasospasm of digital arteries triggered by cold or emotional stress. Primary Raynaud has no identifiable underlying cause and likely reflects abnormal vascular smooth muscle regulation. Secondary Raynaud results from an associated condition, most often systemic sclerosis or another connective tissue disease, as well as certain drugs, vibration exposure, or hematologic disorders.
What are the first symptoms of Raynaud syndrome?
The first symptoms are usually sudden color changes in the fingers after cold exposure or stress, often starting with pallor (whiteness), followed by bluish discoloration, and then redness as blood flow returns. Numbness, tingling, or cold sensation accompanies the pallor phase, with throbbing or burning pain sometimes occurring during rewarming.
How is Raynaud syndrome diagnosed?
Diagnosis is primarily clinical, based on a history of episodic triphasic color changes triggered by cold or stress. Nailfold capillaroscopy and ANA testing help distinguish primary from secondary Raynaud; abnormal capillaries or positive specific autoantibodies suggest an underlying connective tissue disease and warrant further rheumatologic evaluation.
Is Raynaud syndrome curable?
Primary Raynaud is not 'cured' but is generally manageable and benign, often improving with lifestyle measures like avoiding cold and stress, and does not damage tissue. Secondary Raynaud cannot be cured either, but symptoms and complications can be controlled with vasodilator therapy and by treating the underlying connective tissue disease.
Raynaud syndrome vs acrocyanosis — what is the difference?
Raynaud syndrome causes episodic, triphasic color changes (white-blue-red) triggered by cold or stress, with normal color between episodes. Acrocyanosis causes persistent, painless bluish discoloration of the hands and feet without a pallor phase and without discrete episodes, and it does not progress to ulceration or gangrene.
What is the difference between primary and secondary Raynaud phenomenon?
Primary Raynaud occurs without any underlying disease, typically in young women, with symmetric involvement, normal nailfold capillaries, and a benign course. Secondary Raynaud is associated with an underlying disorder, most often systemic sclerosis, tends to start later in life, may be asymmetric, shows abnormal nailfold capillaries, and carries risk of digital ulceration or gangrene.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: I73.0
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.